Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona

Microbial Drug Resistance

Volumn 11, Issue 2, 2005, Pages 107-114

  Coll, Pere ^a,b   Aragón, Lina Marcela ^a,b   Alcaide, Fernando ^c   Espasa, Mateo ^d   Garrigó, Montserrat ^a,b   González, Julià ^d   Manterola, Jose M ^b,e   Orús, Pilar ^c   Salvadó, Margarita ^f  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; ISONIAZID; PEROXIDASE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARBOXY TERMINAL SEQUENCE; CODON; ENZYME ACTIVITY; GENE DELETION; GENE LOCUS; GENE MUTATION; KATG GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY SEQUENCE; SPAIN;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 18944384602     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.107     Document Type: Article

References (56)

1. Bakonyte, D., A. Baranauskaite, J. Cicenaite, A. Sosnovskaja, and P. Stakenas. 2003. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob. Agents Chemother. 47:2009-2011.
2. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K.S. Um, T. Wilson, D. Collins, G. de Lisle, and W.R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
3. Banerjee, A., M. Sugantino, J.C. Sacchettini, and W.R. Jacobs, Jr. 1998. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144:2697-2704.
4. Bártfai, Z., Á. Somoskövi, C. Ködmön, N. Szabó, E. Puskás, L. Kosztolányi, E. Faragó, J. Mester, L.M. Parsons, and M. Salfinger. 2001. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hurgary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 39:3736-3739.
5. Canneti, G., and J. Grosset. 1968. Techniques et indications des examens bactériologiques en tuberculose. Éditions de la Tourelle, Saint Mandé.
6. Cardona, P.J., S. Gordillo, I. Amat, J. Díaz, J. Lonca, C. Vilaplana, A. Pallarés, R. Llatjós, A. Ariza, and V. Ausina. 2003. Catalase-peroxidase activity has no influence on virulence in a murine model of tuberculosis. Tuberculosis 83:351-359.
7. Chaves, F., M. Alonso-Sanz, M.J. Rebollo, J.C. Tercero, M.S. Jimenez, and A.R. Noriega. 2000. rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 4:765-770.
8. Dahle, U.R., P. Sandven, E. Heldal, T. Mannsaaker, and D.A. Caugant. 2003. Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 41:67-72.
9. Dobner, P., S. Rüsch-Gerdes, G. Bretzel, K. Feldmann, M. Rifai, T. Löscher, and H. Rinder. 1997. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 1:365-369.
10. García de Viedma, D., M. del Sol Díaz Infantes, F. Lasala, F. Chaves, L. Alcalá, and E. Bouza. 2002. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 40:988-995.
11. Gillespie, S.H., O.J. Billington, A. Breathnach, and T.D. McHugh. 2002. Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts. Microb. Drug Resist. 8:273-279.
12. Heym, B., P.M. Alzari, N. Honore, and S.T. Cole. 1995. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol. Microbiol. 15:235-245.
13. Heym, B., B. Saint-Joanis, and S.T. Cole. 1999. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Tuberc. Lung Dis. 79:267-271.
14. Heym, B., E. Stavropoulos, N. Honoré, P. Domenech, B. Saint-Joanis, T.M. Wilson, D.M. Collins, M.J. Colston, and S.T. Cole. 1997. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect. Immun. 65:1395-1401.
15. Hirano, K., C. Abe, and M. Takahashi. 1999. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol. 37:2663-2666.
16. Kelley, C.L., D.A. Rouse, and S.L. Morris. 1997. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:2057-2058.
17. Kiepiela, P., K.S. Bishop, A.N. Smith, L. Roux, and D.F. York. 2000. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuberc. Lung Dis. 80:47-56.
18. Kim, S.Y., Y.J. Park, W.I. Kim, S.H. Lee, C. Ludgerus Chang, S.J. Kang, and C.S. Kang. 2003. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn. Microbiol. Infect. Dis. 47:497-502.
19. Larsen, M.H., C. Vilchèze, L. Kremer, G.S. Besra, L. Parsons, M. Salfinger, L. Heifets, M.H. Hazbon, D. Alland, J.C. Sacchettini, and W.R. Jacobs, Jr. 2002. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol. Microbiol. 46:453-466.
20. Lee, A.S., A.S. Teo, and S.Y. Wong. 2001. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 45:2157-2159.
21. Lee, H., S.N. Cho, H.E. Bang, J.H. Lee, G.H. Bai, S.J. Kim, and J.D. Kim. 2000. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. Int. J. Tuberc. Lung Dis. 4:441-447.
22. March, F., P. Coll, R.A. Guerrero, E. Busquets, J.A. Caylà, and G. Prats. 2000. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 14:525-535.
23. Martin-Casabona, N., F. Alcaide, P. Coll, J. González, J.M. Manterola, M. Salvado, and J.A. Cayla. 2000. Fármaco resistencia en Mycobacterium tuberculosis. Estudio multicéntrico del área de Barcelona. Med. Clin. (Barc.) 115:493-498.
24. Marttila, H.J., H. Soini, E. Eerola, E. Vyshnevskaya, B.I. Vyshnevskiy, T.F. Otten, A.V. Vasilyef, and M.K. Viljanen. 1998. A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother. 42:2443-2445.
25. Morlock, G.P., B. Metchock, D. Sikes, J.T. Crawford, and R.C. Cooksey. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805.
26. Musser, J.M., V. Kapur, D.L. Williams, B.N. Kreiswirth, D. van Soolingen, and J.D. van Embden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
27. Piatek, A.S., A. Telenti, M.R. Murray, H. El-Hajj, W.R. Jacobs, Jr., F.R. Kramer, and D. Alland. 2000. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44:103-110.
28. Pym, A.S., B. Saint-Joanis, and S.T. Cole. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70: 4955-4960.
29. Ramaswamy, S., and J.M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79:3-29.
30. Ramaswamy, S.V., R. Reich, S.J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E.A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47: 1241-1250.
31. Rattan, A., A. Kalia, and N. Ahmad. 1998. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg. Infect. Dis. 4:195-209.
32. Rindi, L., L. Bianchi, E. Tortoli, N. Lari, D. Bonanni, and C. Garzelli. 2003. A real-time PCR assay for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J. Microbiol. Methods 55:797-800.
33. Ristow, M., M. Mohlig, M. Rifai, H. Schatz, K. Feldmann, and A. Pfeiffer. 1995. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 346:502-503.
34. Rouse, D.A., J.A. DeVito, Z. Li, H. Byer, and S.L. Morris. 1996. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol. Microbiol. 22:583-592.
35. Rozwarski, D.A., G.A. Grant, D.H. Barton, W.R. Jacobs, Jr., and J.C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98-102.
36. Saint-Joanis, B., H. Souchon, M. Wilming, K. Johnsson, P.M. Alzari, and S.T. Cole. 1999. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem. J. 338:753-760.
37. Schilke, K., K. Weyer, G. Bretzel, B. Amthor, J. Brandt, V. Sticht-Groh, P.B. Fourie, and W.H. Haas. 1999. Universal pattern of rpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa. Int. J. Tuberc. Lung Dis. 3:620-626.
38. Scior, T., I. Meneses Morales, S.J. Garces Eisele, D. Domeyer, and S. Laufer. 2002. Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis-a review. Arch. Pharm. (Weinheim) 335:511-525.
39. Sherman, D.R., K. Mdluli, M.J. Hickey, T.M. Arain, S.L. Morris, C.E. Barry, III, and C.K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
40. Silva, M.S., S.G. Senna, M.O. Ribeiro, A.R. Valim, M.A. Telles, A. Kritski, G.P. Morlock, R.C. Cooksey, A. Zaha, and M.L. Rossetti. 2003. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41:4471-4447.
41. Slayden, R.A., and C.E. Barry, III. 2000. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect. 2:659-669.
42. Solsona, J., J.A. Cayla, E. Verdu, M.P. Estrada, S. Garcia, D. Roca, B. Miquel, P. Coll, and F. March. 2001. Molecular and conventional epidemiology of tuberculosis in an inner city district. Int. J. Tuberc. Lung Dis. 5:724-731.
43. Somoskovi, A., L.M. Parsons, and M. Salfinger. 2001. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2:164-168.
44. Sreevatsan, S., X. Pan, Y. Zhang, V. Deretic, and J.M. Musser. 1997. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 41:600-606.
45. Telenti, A. 1998. Genetics and pulmonary medicine. 5. Genetics of drug-resistant tuberculosis. Thorax 53:793-797.
46. Telenti, A., N. Honoré, C. Bernasconi, J. March, A. Ortega, B. Heym, H.E. Takiff, and S.T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
47. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M.J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
48. Torres, M.J., A. Criado, M. Ruiz, A.C. Llanos, J.C. Palomares, and J. Aznar. 2003. Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Diagn. Microbiol. Infect. Dis. 45:207-212.
49. Tudó, G., J. González, R. Obama, J.M. Rodríguez, J.R. Franco, M. Espasa, P.R. Simarro, G. Escaramís, C. Ascaso, A. García, and M.T. Jiménez de Anta. 2004. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int. J. Tuberc. Lung Dis. 8:15-22.
50. Valim, A.R., M.L. Rossetti, M.O. Ribeiro, and A. Zaha. 2000. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil. J. Clin. Microbiol. 38: 3119-3122.
51. van Embden, J.D., M.D. Cave, J.T. Crawford, J.W. Dale, K.D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T.M. Shinnick, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
52. van Soolingen, D., P.E. de Haas, P.W. Hermans, and J.D. van Embden. 1994. DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol. 235:196-205.
53. van Soolingen, D., P.E. de Haas, H.R. van Doorn, E. Kuijper, H. Rinder, and M.W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 182:1788-1790.
54. Wei, C.J., B. Lei, J.M. Musser, and S.C. Tu. 2003. Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob. Agents Chemother. 47:670-675.
55. WHO. 2000. Anti-tuberculosis drug resistance in the world. Report no. 2. Prevalence and trends. World Health Organization, Geneva, Switzerland.
56. WHO. 2003. World Health Organization annual report on global tuberculosis. World Health Organization, Geneva, Switzerland.